https://www.avient.com/industries/healthcare/labware-diagnostics/laboratory-equipment
Laboratory equipment used in diagnostics and research comprises a variety of devices, from Petri dishes, tubes, flasks, and slide storages to manual and automatic pipettes, spatulas, swab sticks, and PCR plates.
Explore how Trilliant™ conductive formulations help solve the performance challenges for pipette tip applications
Explore how Trilliant™ conductive formulations help solve the performance challenges for pipette tip applications (Chinese language version)
https://www.avient.com/industries/healthcare/drug-delivery-systems/auto-injectors-and-drug-delivery-pens
From colorants and additives that provide brand differentiation to thermoplastic elastomers that allow ergonomic designs, our solutions help optimize product performance.
Learn how chemically resistant Trilliant™ HC thermoplastics and Versaflex™ HC TPEs provide enhanced durability to withstand common hospital cleaners and disinfectants
Learn how Mevopur™ Healthcare Functional Additives help protect and enhance the performance of polymers used in healthcare applications
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520Jefferies%2520Conf%2520w%2520Non%2520GAAP%252008%252012%25202014.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which
could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated
savings and operational benefits from the asset realignment;
Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;
Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition
being accretive;
Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability
and cost of credit in the future;
The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with
inadequate liquidity) to maintain their credit availability;
The speed and extent of an economic recovery, including the recovery of the housing market;
Our ability to achieve new business gains;
The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;
Changes in polymer consumption growth rates in the markets where we conduct business;
Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
Fluctuations in raw material prices, quality and supply and in energy prices and supply;
Production outages or material costs associated with scheduled or unscheduled maintenance programs;
Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working
capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;
An inability to raise or sustain prices for products or services;
An inability to maintain appropriate relations with unions and employees;
The inability to achieve expected results from our acquisition activities;
Our ability to continue to pay cash dividends;
The amount and timing of repurchases of our common shares, if any; and
Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates
and changes in the rate of inflation.
The above list of factors is not exhaustive.
We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.
PolyOne Corporation Page 2
Use of Non-GAAP Measures
This presentation includes the use of both GAAP (generally accepted accounting
principles) and non-GAAP financial measures.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520Credit%2520Suisse%2520w%2520non%2520GAAP%25206%252025%25202014.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which
could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated
savings and operational benefits from the asset realignment;
Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;
Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition
being accretive;
Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability
and cost of credit in the future;
The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with
inadequate liquidity) to maintain their credit availability;
The speed and extent of an economic recovery, including the recovery of the housing market;
Our ability to achieve new business gains;
The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;
Changes in polymer consumption growth rates in the markets where we conduct business;
Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
Fluctuations in raw material prices, quality and supply and in energy prices and supply;
Production outages or material costs associated with scheduled or unscheduled maintenance programs;
Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working
capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;
An inability to raise or sustain prices for products or services;
An inability to maintain appropriate relations with unions and employees;
The inability to achieve expected results from our acquisition activities;
Our ability to continue to pay cash dividends;
The amount and timing of repurchases of our common shares, if any; and
Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates
and changes in the rate of inflation
PolyOne Corporation Page 3
Use of Non-GAAP Measures
This presentation includes the use of both GAAP (generally accepted accounting
principles) and non-GAAP financial measures.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520GS%2520w%2520non%2520GAAP%25205_21_14.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual
results to differ materially from those expressed in or implied by the forward-looking statements.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
The final amount of charges resulting from the planned manufacturing realignment and the Company’s ability to realize anticipated savings and
operational benefits from the asset realignment;
Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;
Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being
accretive;
Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and
cost of credit in the future;
The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate
liquidity) to maintain their credit availability;
The speed and extent of an economic recovery, including the recovery of the housing market;
Our ability to achieve new business gains;
The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;
Changes in polymer consumption growth rates in the markets where we conduct business;
Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
Fluctuations in raw material prices, quality and supply and in energy prices and supply;
Production outages or material costs associated with scheduled or unscheduled maintenance programs;
Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital
reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;
An inability to raise or sustain prices for products or services;
An inability to maintain appropriate relations with unions and employees;
The inability to achieve expected results from our acquisition activities;
Our ability to continue to pay cash dividends;
The amount and timing of repurchases of our common shares, if any; and
Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and
changes in the rate of inflation.
• The above list of factors is not exhaustive.
• We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.
Forward – Looking Statements
Page 2
• This presentation includes the use of both GAAP (generally accepted accounting
principles) and non-GAAP financial measures.
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Global%2520Engineered%2520Materials.pdf
Nikrant
Page 67
United
States
36%
Europe
36%
Canada
2%
Asia
20%
Latin
America
2011 Revenue: $0.6 Billion2011 Revenue: $0.6 Billion SolutionsSolutions
At a Glance
Appliance
6% Building &
Construction
3%
Wire & Cable
14%
Electrical &
Electronics
14%Consumer
21%
Packaging
5%
Industrial
8%
Misc.
3%
HealthCare
5%
Transportation
21%
America
6%
2011 Revenue by Industry Segment2011 Revenue by Industry Segment
1.1% 1.3%
3.4%
5.1%
9.6%
8.0%
12-16%
2006 2007 2008 2009 2010 2011 2015
Operating Income % of Sales
Target
Expanding ProfitsExpanding Profits
Page 68
Value Proposition
• GSEM is a global leader providing complete specialty solutions encompassing
innovative technologies and services to enable customer success
Transformation Highlights
• Dramatic turnaround of the Engineered Materials business through mix
improvement and specialty focus
Value Proposition and Transformation Highlights
improvement and specialty focus
• GLS acquisition successfully integrated, having more than
doubled earnings in 3 years
• PolyOne culture and strategy now engrained worldwide
• Expansion into healthcare with dedicated resources
> $15B Addressable Market
Page 69
• Polymer design, formulation and service expertise
• Broad, global technology base and regional centers
of excellence
• Ten innovation centers around the world
Key Differentiators
• Ten innovation centers around the world
• Specialty brand leadership with
PolyOne, GLS, NEU and ECCOH
• Ability to leverage global key
account team
Page 70
From Volume
Commodity-driven product portfolio
To Value
Specialty technology and solutions
EM North America Transformation
Volume Sales Gross Margin $
Mix Transformation – Executing the Strategy
2006 2011 2006 2011 2006 2011
Page 71
$12
$29
Operating Income
($ in millions)
• Provided access to new customers
in specialized, high-growth markets
such as healthcare and consumer
• Strategic partner to many of the
world’s best-known companies
GLS Integration Success
16.9%
8.2%
2007 2011
2007 2011
Working Capital % of Sales
• Complementary global footprint
provided additional cross-selling
opportunities
• Opportunity to expand margins
and drive working capital
improvement while remaining
customer-focused
Page 72
$1.3
$27.6
2006 2011
Healthcare Revenue
• Investment in dedicated
healthcare team to drive
penetration and growth
• Leverage product portfolio
globally & win specialty business
Areas of Focus
$10.5
$117.9
2006 2011
Consumer Revenue
2006 2011globally & win specialty business
in targeted markets
• Aggressively commercialize
specialty innovation platforms
• Utilize our innovation centers to
influence OEM design
(Revenue in $ millions)
Page 73
• Carbon Nanotube Formulations
� Applications: Semiconductor equipment, hard drives
� Customer benefits: Scrap cost reduction and
clean conductivity
• Thermally Conductive Solutions
Applications: Sockets and bulb holders for LED lighting
Key Innovations
� Applications: Sockets and bulb holders for LED lighting
� Customer benefits: Cost reduction, energy saving, and
design flexibility
• FDA-Regulated TPEs
� Applications: Food packaging seals, intravenous delivery
systems, medical stoppers, prefilled syringes
� Customer benefits: Clean and safe elastomers for highly
regulated applications
Page 74
Critical Imperatives and 2015 Goal
Critical Imperatives
• Commercialize critical new technology platforms
• Manage the mix as we continue to drive
the transformation
• Global translation of commercial successes
2015 Goal
• 12 - 16% return on sales
Page 75
Page 76
https://www.avient.com/industries/packaging/beverage-packaging
Keep your oxygen sensitive and light sensitive products tasting great with our UV blocking and oxygen scavenging additive solutions.
From top to bottom, we have your needs covered.
We can help you deliver differentiated dairy packaging that protects your sensitive milk products from UV and extends shelf life.
https://www.avient.com/investor-center/news/polyone-barrier-technologies-enable-sustainability-and-recyclability-packaging
This technology protects light-sensitive dairy products such as ultra-pasteurized milk and protein-enhanced yogurts from photo-induced degradation by providing 99.99% UV and visible-light blocking.
For this reason, Lactra SX was recently awarded the China Sustainable Packaging Award 2017 from M.
They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
https://www.avient.com/industries/packaging/cosmetics-packaging/applicators
From mascara brushes to lip gloss wands, applicators are becoming more unique and specialized.
How Gravi-Tech makes the difference for packaging closures in the luxury cosmetics and spirits markets
How can you make the most of color, from design through processing?
https://www.avient.com/company/sustainability/people/community-service
From blood drives to food drives, and from elementary classrooms to high school mentorship programs, Avient associates pitch in to help make where we live a better place.
Message from VP Sustainability
How Our Products Enable Sustainability